Dr. Michal L. Schwartzman obtained her Ph.D. from Tel Aviv University in 1981. She joined the Pharmacology Department at New York Medical College in 1981 as a Postdoctoral Fellow on an NIH Fogarty Fellowship and rose to the rank of full Professor in 1993. She is currently Chair of the Department of Pharmacology at New York Medical College School of Medicine. She is nationally and internationally recognized for her research which focuses on the role of lipid autacoids in the regulation of vascular function, inflammation and metabolism in the areas of cardiovascular and metabolic diseases. The chemical structure, biological function and mechanism of action of some of these lipids have been identified in Dr. Schwartzman’s laboratory. Currently she is utilizing gene targeting, transgenic animals and human material to elucidate the pathophysiological significance of these molecules in promoting hypertension and insulin resistance. She has published more than 240 manuscripts in peer-reviewed journals, including Nature, Science, PNAS, JCI and Circulation Research. Dr. Schwartzman is a recipient of numerous awards, including the Dean’s Distinguished Research Award, and has held continuous NIH funding since 1981. Dr. Schwartzman has served on NIH study sections, NIH review panels and journal editorial boards. She is the current editor of the journal Prostaglandins and Other Lipid Mediators.
Michal Laniado Schwartzman, Ph.D.
Professor and Chair
Department of Pharmacology
New York Medical College
Basic Sciences Building Rm. 527A
Phone: (914) 594-3116
Fax: (914) 347-4956